In 505 men with high-risk prostate cancer on long-term ADT, 80 Gy vs 70 Gy radiotherapy gave 5-year progression-free survival of 91.4% vs 88.1%; post hoc 10-year rates were 83.6% vs 72.2% (HR 0.56). Severe toxicity was similar between groups.
Secondary analysisn = 505
Hennequin et al. High-dose radiotherapy in patients with high-risk prostate cancers treated with long-term androgen deprivation therapy (GETUG AFU 18): a randomised, phase 3 trial